MicroRNA Expression Panel

Human, Mouse, and Rat

Identify and validate miRNA biomarkers faster and more reproducibly than RNA-Seq or qPCR-based platforms using the miRNA Expression Panel. Analyze up to 800 biologically relevant miRNAs in a single sample, avoiding bias introduced from reverse transcription and amplification techniques.

Benefits

01

Reliably detect and quantitate the most biologically relevant human, mouse and rat miRNAs.

02

Avoid amplification and reverse transcription bias with NanoString’s molecular barcode technology.

03

Assay is suitable for use on complex biological samples such as FFPE, cell lysates, exosomes and biofluids.

Details & data

miRNA Panel Overview

MicroRNAs are a class of small, non-coding RNAs that regulate gene expression of target mRNAs and have been implicated in the widespread control of critical biological processes such as proliferation, differentiation, and apoptosis. The relative abundance of stable circulating miRNAs associated with different disease states offers the potential for discovery of novel biomarkers and new biological insights. The miRNA target genes in the NanoString miRNA panel have either been sequenced with high confidence or found to be clinically relevant.

Genes in panel

Need CLIA Certified NanoString Services?

Fill out this form and one of our scientists will contact you.

Pricing

miRNA > NanoString miRNA

$5,459.00

Up to 12 samples per order analyzed.

$

Please add some options to render this input.

Step 3

Price

Number of samples
$5,459.00*
*price includes reagents
REQUEST A QUOTE
SKU: nanostring-mirna. Categories: , , , . Tag:
Genes: ..
.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................

Tag: